These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11534417)

  • 1. [Predicting factors in the efficacy of interferon treatment in chronic hepatitis C].
    Rodríguez Agulló JL
    An Med Interna; 2001 Jul; 18(7):349-50. PubMed ID: 11534417
    [No Abstract]   [Full Text] [Related]  

  • 2. [Interferon treatment of chronic hepatitis C viral hepatitis patients with normal transaminases].
    Remy AJ; Blanc P
    Gastroenterol Clin Biol; 1998; 22(8-9):748-9. PubMed ID: 9823572
    [No Abstract]   [Full Text] [Related]  

  • 3. [Interferon therapy in chronic hepatitis C and cellular immunity].
    Nikitin IG; Kuznetsov SL; Mordvinova LN; Uskov IuI; Storozhakov GI; Strochenovskiĭ AB
    Klin Med (Mosk); 1999; 77(6):33-7. PubMed ID: 10459217
    [No Abstract]   [Full Text] [Related]  

  • 4. SNPs in the promoter region of the osteopontin gene as a marker predicting the efficacy of interferon-based therapies in patients with chronic hepatitis C.
    Naito M; Matsui A; Inao M; Nagoshi S; Nagano M; Ito N; Egashira T; Hashimoto M; Mishiro S; Mochida S; Fujiwara K
    J Gastroenterol; 2005 Apr; 40(4):381-8. PubMed ID: 15868370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of interferon therapy for aged patients with chronic hepatitis C.
    Arase Y; Kumada H
    J Gastroenterol; 2004 Nov; 39(11):1123-4. PubMed ID: 15580412
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of chronic hepatitis C in patients not responding to interferon].
    Moreno Monteagudo JA; García Buey L; Moreno Otero R
    Gastroenterol Hepatol; 2000 Feb; 23 Suppl 1():51-6. PubMed ID: 11968345
    [No Abstract]   [Full Text] [Related]  

  • 7. APRI-M6 for predicting long-term outcome of chronic hepatitis C patients after interferon-based therapy: more questions than answers.
    Su TH; Kao JH; Chen DS
    Hepatology; 2007 Jun; 45(6):1586-7; author reply 1587-8. PubMed ID: 17538939
    [No Abstract]   [Full Text] [Related]  

  • 8. [Efficacy forecast on interferon in the treatment of chronic viral hepatitis].
    Mei YY; Gao ZL
    Zhonghua Gan Zang Bing Za Zhi; 2011 Jan; 19(1):8-9. PubMed ID: 21272450
    [No Abstract]   [Full Text] [Related]  

  • 9. Interferon: the quintessence of a quinquagenarian.
    De Clercq E
    Verh K Acad Geneeskd Belg; 2009; 71(1-2):5-14. PubMed ID: 19739395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-based therapy for dialysis patients with chronic hepatitis C: progress and challenges.
    Liu CH; Liu CJ; Kao JH
    Nephrology (Carlton); 2007 Feb; 12(1):8-10. PubMed ID: 17295654
    [No Abstract]   [Full Text] [Related]  

  • 11. [Interferons and chronic hepatitis C treatment].
    Cai DC; Ren H
    Zhonghua Gan Zang Bing Za Zhi; 2007 Nov; 15(11):847-8. PubMed ID: 18073070
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of chronic hepatitis C in patients without previous treatment].
    Dehesa Violante M
    Rev Gastroenterol Mex; 2002 Oct; 67 Suppl 2():S42-4. PubMed ID: 12712852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can interferon prolong life?
    Esteban R
    Hepatology; 2003 Aug; 38(2):292-4. PubMed ID: 12883472
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of chronic hepatitis C. Combined treatment in naive patients].
    Forns Bernhardt X
    Gastroenterol Hepatol; 2000 Feb; 23 Suppl 1():43-6. PubMed ID: 11968343
    [No Abstract]   [Full Text] [Related]  

  • 15. [Long-term outcomes of interferon therapy for chronic hepatitis].
    Dou XG; Zhao LR
    Zhonghua Gan Zang Bing Za Zhi; 2011 Jan; 19(1):10. PubMed ID: 21272451
    [No Abstract]   [Full Text] [Related]  

  • 16. [Chronic hepatitis C. A new chance with Consensus Interferon for patients with handicaps].
    MMW Fortschr Med; 2002 Nov; 144(45):56-7. PubMed ID: 12534066
    [No Abstract]   [Full Text] [Related]  

  • 17. Review article: predicting response in hepatitis C virus therapy.
    Mihm U; Herrmann E; Sarrazin C; Zeuzem S
    Aliment Pharmacol Ther; 2006 Apr; 23(8):1043-54. PubMed ID: 16611264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined effect of an ACE inhibitor, perindopril, and interferon on liver fibrosis markers in patients with chronic hepatitis C.
    Yoshiji H; Noguchi R; Fukui H
    J Gastroenterol; 2005 Feb; 40(2):215-6. PubMed ID: 15770410
    [No Abstract]   [Full Text] [Related]  

  • 19. Psychological screening before interferon therapy.
    Scalori A; Apale P; Roffi L
    Hepatology; 2001 Feb; 33(2):480. PubMed ID: 11172355
    [No Abstract]   [Full Text] [Related]  

  • 20. [Similar poor response in genotype 4 chronic Hepatitis C treatment with interferon and ribavirin compared with genotype 1 treatment].
    Pérez Mota A; Graus J; García Flores MA; Blanco M; Pérez-Muñoz C; Villalgordo C; Rodero R
    Rev Esp Enferm Dig; 2003 Mar; 95(3):238-9. PubMed ID: 12760714
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.